Naturewise Biotech & Medicals Corporation(TW:4732)
NT$14.90+0.00 (+0.68%)
TW:4732
Naturewise Biotech & Medicals Corporation Revenue
NT$14.90
At close:+0.00 (+0.68%)
Naturewise Biotech & Medicals Corporation (4732) Revenue
Naturewise Biotech & Medicals Corporation Revenue
Naturewise Biotech & Medicals Corporation had a revenue of 84.62M in the quarter ending Jun 30, 2026, with -5.98%. This bring the company's revenue in the last twelve months to 174.62M, Decreased 1.21%. In the fiscal year ending Dec 31, 2025, Naturewise Biotech & Medicals Corporation had annual revenue of 176.77M with -21.20% growth.
- Revenue (ttm)
- 174.62M
- Revenue Growth
- -3.15%
- P/S Ratio
- 4.18
- Revenue/Employee
- TWD 5,524,000
- Employees
- 32
- Market Cap
- TWD 739.69M
Revenue Chart
Naturewise Biotech & Medicals Corporation Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 176.77M | -47.55M | -21.20% |
| Dec 31, 2024 | 224.32M | 64.18M | 40.08% |
| Dec 31, 2023 | 160.14M | -68.45M | -29.94% |
| Dec 31, 2022 | 228.59M | -21.21M | -8.49% |
| Dec 31, 2021 | 249.80M | -57.12M | -18.61% |
| Dec 31, 2020 | 306.92M | -546.00K | -0.18% |
| Dec 31, 2019 | 307.46M | 198.99M | 183.43% |
| Dec 31, 2018 | 108.48M | 39.38M | 56.98% |
| Dec 31, 2017 | 69.10M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.